Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    August 2017
  1. SHORE ND, Boorjian SA, Canter DJ, Ogan K, et al
    Intravesical rAd-IFNalpha/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Clin Oncol. 2017 Aug 23:JCO2017723064. doi: 10.1200/JCO.2017.72.3064.
    PubMed     Text format     Abstract available


    July 2017
  2. BALAR AV
    Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
    J Clin Oncol. 2017;35:2109-2112.
    PubMed     Text format     Abstract available


    April 2017
  3. KULKARNI GS, Hermanns T, Wei Y, Bhindi B, et al
    Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Clin Oncol. 2017 Apr 14:JCO2016692327. doi: 10.1200/JCO.2016.69.2327.
    PubMed     Text format     Abstract available


    January 2017
  4. POWLES T, Huddart RA, Elliott T, Sarker SJ, et al
    Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    J Clin Oncol. 2017;35:48-55.
    PubMed     Text format     Abstract available


    July 2016
  5. DRAKE CG, Bivalacqua TJ, Hahn NM
    Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select.
    J Clin Oncol. 2016 Jul 25. pii: JCO684696.
    PubMed     Text format    


  6. PAL SK, Agarwal N, Boorjian SA, Hahn NM, et al
    National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
    J Clin Oncol. 2016 Jul 25. pii: JCO681429.
    PubMed     Text format    


  7. EAPEN LJ, MacRae RM
    Management Considerations After Cystectomy for Bladder Cancer.
    J Clin Oncol. 2016 Jul 18. pii: JCO679423.
    PubMed     Text format    


  8. HU YW
    Real-World Role of Adjuvant Chemotherapy in Bladder Cancer.
    J Clin Oncol. 2016 Jul 11. pii: JCO675884.
    PubMed     Text format    


  9. RUGGERI EM, Fabbri MA, Nelli F
    Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?
    J Clin Oncol. 2016 Jul 11. pii: JCO675132.
    PubMed     Text format    


    June 2016
  10. GALSKY MD, Stensland K, Sfakianos JP, Mehrazin R, et al
    Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement.
    J Clin Oncol. 2016 Jun 6. pii: JCO675033.
    PubMed     Text format     Abstract available


  11. MASSARD C, Gordon MS, Sharma S, Rafii S, et al
    Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.
    J Clin Oncol. 2016 Jun 6. pii: JCO679761.
    PubMed     Text format     Abstract available


    March 2016
  12. MILOWSKY MI, Rumble RB, Booth CM, Gilligan T, et al
    Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    J Clin Oncol. 2016 Mar 21. pii: JCO659797.
    PubMed     Text format     Abstract available


    January 2016
  13. KAMAT AM, Sylvester RJ, Bohle A, Palou J, et al
    Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.
    J Clin Oncol. 2016 Jan 25. pii: JCO644070.
    PubMed     Text format     Abstract available


  14. KUSHI LH, Quinn VP, Ghai NR, Roh JM, et al
    Identifying lifestyle and genetic factors to prevent recurrence of non-muscle invasive bladder cancer in a prospective cohort study at Kaiser Permanente (the Be-Well study).
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  15. DANFORTH KN, Kwan ML, Bulkley JE, O'Keeffe-Rosetti MC, et al
    Recovery challenges faced by bladder cancer survivors after recent cystectomy and urinary diversion.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  16. GALSKY MD, Stensland KD, Moshier E, Sfakianos JP, et al
    Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.
    J Clin Oncol. 2016 Jan 19. pii: JCO641076.
    PubMed     Text format     Abstract available


  17. SONPAVDE G, Gordetsky JB, Lockhart ME, Nix JW, et al
    Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
    J Clin Oncol. 2016 Jan 19. pii: JCO654442.
    PubMed     Text format     Abstract available


  18. PAL SK, Agarwal N, Grivas P, Choueiri T, et al
    Adjuvant Chemotherapy for Bladder Cancer: Using Population-Based Data to Fill a Void of Prospective Evidence.
    J Clin Oncol. 2016 Jan 19. pii: JCO654368.
    PubMed     Text format    


    August 2015
  19. MARTIN-DOYLE W, Orsola A, Bellmunt J
    Reply to K. Lu.
    J Clin Oncol. 2015;33:2716-7.
    PubMed     Text format    


    July 2015
  20. LU K
    Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.62.2712.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: